PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50120C00171Eo14042 inv-102 for the treatment of — Invirsa Inc

Invirsa Inc holds $22.0M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Nov 16, 2028 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Invirsa Inc

Recipient

Nov 16, 2028

PoP end

$22M

Obligated

541714

NAICS

AZ13

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

NONE

Contract number75A50120C00171

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentInvirsa Inc

UEISN3VBD5EQMK6

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAZ13

Place of performanceCOLUMBUS, OH

Related solicitationBAA-18-100-SOL-00003

PoP end (current)Nov 16, 2028

Obligated$22M

EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3. is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Invirsa Inc. Estimated value $39M ($22M obligated). Current period of performance ends Nov 16, 2028. Last award drew 1 bidder. Place of performance: COLUMBUS, OH. Related solicitation BAA-18-100-SOL-00003.

EO14042 INV-102 FOR THE TREATMENT OF MUSTARD GAS KERATOPATHY UNDER BAA-18-100-SOL-00003, AREA OF INTEREST 5.3.

Recompete timing

Public

● Expiring in 781 days

Current PoP ends Nov 16, 2028 (781 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around May 16, 2027.

Bonuses end Sept 30

Want the durability read on 75A50120C00171? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Invirsa Inc — $22.0M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$22.0M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50120C00171?

75A50120C00171 (Eo14042 inv-102 for the treatment of) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $39M, currently held by Invirsa Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50120C00171?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50120C00171 to Invirsa Inc.

Who is the incumbent on 75A50120C00171?

Invirsa Inc is the incumbent with $22.0M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Nov 16, 2028.

When does Invirsa Inc’s 75A50120C00171 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 16, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50120C00171? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action May 8, 2026